DB22/T 396-2014 Healthcare product toxicological evaluation procedures and testing methods

DB22/T 396-2004 Healthcare product toxicological evaluation procedures and testing methods

DB22/T 396.12-2017 Healthcare product toxicological evaluation procedures and testing methods - Part 12: Skin patch test in humans DB22/T 396.11-2017 Toxicological Evaluation Procedure and Test Methods for Healthcare Products - Part 11: Carcinogenicity Test DB22/T 396.10-2017 Healthcare product toxicological evaluation procedures and testing methods - Part 10: Teratogenicity testing. (Note: This is a placeholder translation and the final English translation may differ.) DB22/T 396.9-2017 Toxicological Evaluation Program and Test Methods for Healthcare Products - Part 9: Mammalian Cell Chromosome Aberration Test DB22/T 396.8-2017 Healthcare products toxicological evaluation procedures and testing methods - Part 8: Mouse sperm morphology test DB22/T 396.7-2017 DB22/T 396.7-2017 Toxicological Evaluation Procedures and Test Methods for Healthcare Products - Part 7: Microchromosome Nucleosome Test for Rodents DB22/T 396.6-2017 Healthcare product toxicological evaluation procedures and testing methods - Part 6: Bacterial reverse mutation test DB22/T 396.5-2017 Healthcare product toxicological evaluation procedures and testing methods - Part 5: Skin allergic reaction test DB22/T 396.4-2017 Healthcare product toxicological evaluation procedures and testing methods - Part 4: Skin irritation test DB22/T 396.3-2017 Healthcare product toxicological evaluation procedures and testing methods - Part 3: Long-term transdermal toxicity test DB22/T 396.2-2017 Healthcare product toxicological evaluation procedures and testing methods - Part 2: Acute transdermal toxicity test DB22/T 396.1-2017